All in all, both retatrutide and Mounjaro appear safe and well-tolerated for most people, with manageable side effects
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
Those who are pregnant, breastfeeding, or trying to conceive
The clinical significance hasnt been characterized
Challenges persist, however, including regulatory scrutiny across different regions concerning health claims, competition from established oral supplements and injectable GLP-1 agonists, and the need for robust clinical validation to support efficacy claims for topical applications